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1. Introduction
  Asthma is a chronic disease, involving hypersensitivity 
reaction of the lower respiratory system producing 
obstruction of the airways[1]. It is a disease that does not 
discriminate race, age and gender. Asthma affect about 300 
million people worldwide and it has been estimated that a 
further 100 million will be affect by 2025[2,3]. Asthma is a 
complex inflammatory disease cause’s airway narrowing 
and associated with change in the level of mast cells, 
lymphocytes, cytokines and other inflammatory cell 
products. Despite the advancements in asthma therapy, 
modern medicines are far from satisfactory as they provide 
only symptomatic relief, 
produce several adverse effects and may lose effectiveness 
on continued use. Muscle tremor and hypokalemia are 
major adverse effects of β2 agonists. Theophyline has 
narrow therapeutic index and requires monitoring of 
drug levels[4]. Adverse effects of corticosteroids include 
fluid retention, increased cell mass, increased appetite, 
weight gain, osteoporosis, capillary fragility, hypertension, 
peptic ulceration, diabetes, cataract, and phychosis. 
Hence Ayurveda has recommended number of drugs from 
indigenous plants sources for the treatment of bronchial 
asthma and other allergic disorders and have been 
successful in controlling the disease as well. Large numbers 
of medicinal plant preparations have been reported to 
possess anti-asthmatic effects. 
  Cressa cretica L. (Convolulaceae) (C. cretica), popularly 
known as ‘Rudanti’ in Hindi and is a widely grown 
halophytic plant. Different parts of the plant have been 
claimed to be valuable in a wide spectrum of diseases. In 
earlier studies C. cretica Linn flowers exhibited cytotoxic 
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and anti-inflammatory activity in vitro. C. cretica is 
reported to be antibilous, antituberculosis, expectorant, 
asthma and effective against pulmonary disorder[5]. The 
plant produced intrusion in testosterone production and 
affected spermatogenesis in male albino rats[6]. Previously 
our research team reported anti-tussive activity of the 
plant[7]. More recently we demonstrated anti-inflammatory 
and both in vitro and in vivo antioxidant activity of the 
plant[8, 9]. Shahat and his co workers yielded five flavonoids 
(quercetin, quercetin-3-O-glucoside, kaempferol- 3-O-
rhamnoglucoside, and rutin) from the aerial parts of C. cretica[6].
It is also reported the fruits of C. cretica is a potential 
source of edible oil. The oil of C. cretica was free from any 
undesirable components and could safely be recommended 
for human consumption[10]. In addition the antiviral activity 
from the plant was also reported. Besides this the arial parts 
of the plant contains scopoletin, umbelliferone, isoflavone 
glycoside coumaranochrome glycoside. Syringaresinol 
glucoside and dicaffeoyl quinic acid were also isolated[6].
  In present study, we examined the bronchodilatory activity 
and mast cell stabiling activity of the fractions of C. cretica, 
in order to justify the use of the plant in ethno medicinal use 
in asthma.  
2. Materials and methods
2.1. Collection of plant material
  C. cretica was collected from Nalban island of Chilika 
lake, Orissa, India and was preliminarily identified at the 
Deptartment of Natural Product, Institute of Mineral and 
Material Technology, (formerly known as Regional Research 
laboratory, Bhubaneswar) India and which was later on 
authenticated from Botanical Survey of India, Hawrah, 
West Bengal, India vide access no. (CNH/I-I/32/2010/
Tech.II/237-3). A voucher specimen has been kept in our 
laboratory for future reference.
2.2. Preparation of fraction and phytochemical screening
  The plants were air-dried, pulverized to a coarse powder 
in a mechanical grinder, passed through a 40-mesh sieve 
and extracted in a soxhlet extractor with methanol. The 
extract was decanted, filtered with Whatman No. 1 filter 
paper and concentrated at reduced pressure below 40 曟 
through rota-vapor to obtain dry extract (16.73%w/w). 
C. cretica methanolic extract (CME) was adsorbed on to the 
250 g of silica gel of 60-120 mesh size and fractionated using 
solvents of increasing polarity such as hexane (Fr-He), 
ethylacetate (Fr-Et), and methanol (Fr-Me). The fractions 
were subjected for preliminary phytochemical screening to 
show the presence of steroid, alkaloid, glycoside, tannin, 
triterpenoid, carbohydrates reducing sugar, and fatty acids.
2.3. Animals
  Guinea pigs of (either sex weighing between 300 - 500 g) 
and wistar albino rats (either sex, weighing between 160 - 
220 g) were obtained from animal house, Birla Institute of 
Technology, Mesra, Ranchi, India and kept in polypropylene 
cages with paddy husk as bedding. Animals were housed 
at a temperature of 24 依 2 曟 and relative humidity of 60% 
-70 %. A 10:14 light: dark cycle was followed. All animals 
were allowed to free access to water and fed with standard 
commercial chaw pallets (M/s. Hindustan Lever Ltd, 
Mumbai). All the experimental procedures and protocols 
used in this study were reviewed by the Institutional Animal 
Ethics Committee (Reg. No: 621/02/ac/CPCSEA) and were in 
accordance with the guidelines of the CPCSEA, Ministry of 
Forests and Environment, Government of India. 
2.4. Pharmacological studies
2.4.1. Studies on acetylcholine and histamine induced 
bronchospasm
  Experimental bronchial asthma was induced in guinea 
pigs by exposing them to histamine and acetylcholine 
aerosol.  Guinea pigs were selected and divided into ten 
groups each containing six animals out of which groups 
I-V, were exposed to 0.1% w/v of histamine dihydrochloride 
aerosol and another groups VI -X were exposed to 0.5% w/v
of acetylcholine bromide aerosol. The animals exposed to 
histamine and acetylcholine aerosol showed progressive 
dyspnoea. The end point of preconvulsion dyspnoea (PCD) 
was determined from the time of aerosol exposure to the 
onset of dyspnoea leading to the appearance of convulsion. 
As soon as PCD commenced, the animals were removed from 
chamber and placed in fresh air. This time of PCD was taken 
as day 0 value. Guinea pigs of all groups were treated with Fr-Et 
(100 and 200 mg/kg. p.o.) and Fr-Me (100 and 200 mg/kg. p.o.),
once a day for 7 days. On 7th day 2 h after the last dose, 
the time for the onset of PCD was recorded as on day 0. The 
percentage increased in time of PCD was calculated using 
following formula[11].
  Percentage increased in time of PCD =[1- T1 / T2 ] 伊 100
Where T1 = time for PCD onset on day 0, T2= time for PCD 
onset on day 7
2.4.2. Isolated guinea pig trachea preparation
  The guinea pig was sacrificed by a sharp blow to the neck 
and quickly exsanguinated by carotid artery transaction. 
The trachea was removed and put into a petridish containing 
Krebs-Henseleit solution with the following composition 
(mM): NaCl 118.2, NaHCO3 25.0, CaCL2 2.5, KCl 4.7, KH2PO4 
1.2, MgSO4 1.2 and glucose 11.1 (pH 7.4) pre heated at 37 曟.
It was carefully cleaned of adherent fat and connective 
tissue, and then cut into rings, 2-3 mm wide. Each ring was 
opened by a longitudinal cut on the ventral side opposite 
to the smooth muscle layer, forming a tracheal strip with a 
central part of smooth muscle in between the cartilaginous 
portion on the edges. A tension of 1g was applied to each 
of the tracheal strips and was kept constant throughout the 
experiment[12]. 
2.4.3. Effect of different fractions on the histamine and 
acetylcholine pre-contracted guinea pig trachea
  Test fractions were dissolved in dimethyl sulphoxide 
(DMSO). After equilibration, the strips were contracted 
with histamine (10-6 M), acetylcholine (1-6 M). Then their 
sustained contractions were obtained and relaxant effect of 
the fractions and standard drugs were assayed by adding 
in a cumulative fashion. The percentages of relaxation 
provoked by each concentration were calculated and its IC50 
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was calculated. Standard antihistaminic and anticholinergic 
drug (mepyramine and atropine), respectively were used as 
positive control[13].
2.4.4. Effect of different fractions on KCl pre-contracted 
guinea pig trachea
  After equilibration and stimulation of the organ, it was 
contracted with 80 mM KCl. Their sustained contractions 
were obtained and relaxant effect of the fractions and control 
drugs were assayed by adding in a cumulative fashion. The 
percentages of relaxation provoked by each concentration 
were calculated and its IC50 was calculated. Verapramil, was 
used as a positive control[13].  
2.4.5 Studies on compound 48/80 and egg albumin induced 
rat peritoneal mast cell degranulation
  Normal saline containing 5 units/mL of heparin was 
injected in the peritoneal cavity of male rats lightly 
anaesthetized with ether. After a gentle abdominal message, 
the peritoneal fluid containing mast cells was collected in 
centrifuge tubes placed over ice. Peritoneal fluid of 8 - 10 
rats was collected, pooled and centrifuged at 2 000 rpm for 5 
min. Supernatant solution was discarded and the cells were 
washed twice with saline and resuspended in 1 mL of saline. 
0.1 mL of the peritoneal cell suspension was transferred to 9 
test tubes and were treated as follows:
Test tube no. 1 & 2: Saline
Test tube no. 3: 0.1 mL of 0.5 mg/mL Fr-Et in saline
Test tube no. 4:  0.1mL of 1.0 mg/mL Fr-Et in saline
Test tube no. 5:  0.1mL of 2.0 mg/mL Fr-Et in saline
Test tube no. 6:  0.1 mL of 0.5 mg/mL Fr-Me in saline
Test tube no. 7:  0.1 ml of 1.0 mg/ml Fr-Me in saline
Test tube no. 8:  0.1 ml of 2.0 mg/ml Fr-Me in saline
Test tube no. 9:  0.1 ml of 10 毺g/ml of Ketotifen fumarate
  Each test tube was incubated for 15 min at 37 曟 and then 
compound 48/80 (0.1 mL, 10 μg/mL) was added to each test 
tube except test tube no. 1 and 2. After further incubation for 
10 min. at 37 曟, the cells were stained with 0.1% toluidine 
blue solution made in distilled water and examined under 
the high power of light microscope. Percentage protection 
of the mast cells in the control group and the treated groups 
were calculated by counting the number of degranulated 
mast cells from total of at least 100 mast cells counted.
  In another study, rats were sensitized by administering 
three doses of 350 毺g of egg albumin adsorbed on 60 mg of 
aluminum hydroxide gel, the doses being given on the first, 
third and fifth day subcutaneously. The mast cells were 
collected on the tenth day of sensitization. The study was 
conducted in the same manner as above and the sensitized 
cells were degranulated using egg albumin (1 mg/mL). 
Percentage protection of the mast cells in the control group 
and the treated groups were calculated by counting the 
number of degranulated mast cells from total of at least 100 
mast cells counted. Control group was consisted of positive 
control group in which egg albumin was added without 
addition of test agent and a negative control group in which 
neither egg albumin nor the test agent was added to correct 
the spontaneous degranulation of mast cells without any 
degranulating agent[14].
2.5. Statistical analysis
  Data expressed are mean 依 standard error of mean (SEM, 
n = number of experiment) and the minimum inhibitory 
concentrations (EC50) with 95% confidence intervals (CI). 
Pharmacological data were analysed by one-way analysis 
of variance (ANOVA) followed by Dunnett’s t test for 
comparison with equal sample size. The difference was 
considered significant when P value < 0.05. All the values 
were expressed as mean 依 standard error mean (S.E.M.). 
Preconvulsion dyspnoea time was analyzed through 
student’s paired t test.
3. Result
3.1. Effect of Fr-Et and Fr-Me on acetylcholine and 
histamine induced bronchospasm
  Significant (P<0.05) in preconvulsion time was observed 
due to treatment with Fr-Et and Fr-Me (100 and 200 mg/kg p.o.),
when the guinea pigs were exposed to either histamine 
(0.1%) or acetylcholine (0.5%) aerosol. Fr-Et at the doses 
of 100 and 200 mg/kg p.o. protected histamine induced 
bronchospasm animals by 41.47% and 56.32% respectively 
at the same time Fr-Me can protect 23.83% and 32.79% at 
the dose levels of 100 and 200 mg/kg respectively. Fr-Et at 
the doses of 100 and 200 mg/kg p.o. protected acetylcholine 
induced bronchospasm animals by 30.89% and 37.58% 
where as Fr-Me at the doses of 100 and 200 mg/kg p.o. 21.53%
and 9.12% respectively. The increase in preconvulsion 
time was comparable to that of ketotifen(1 mg/kg p.o.), a 
standard antihistaminic drug and atropine (2 mg/kg p.o.), a 
standard anticholinergic drug and were found to protect the 
bronchospasm induced by acetylcholine and  histamine by 
66.15% and 68.41 % protection respectively. The data are 
shown in Table 1.
3.2. Effect of Fr-Et and Fr-Me on guinea pig trachea
  Both fractions Fr-Et and Fr-Me were first tested on the 
resting baseline of the tissue. The fractions were found 
devoid of any contractile effect up to the dose of 10 mg/mL.
In tracheal preparations, Fr-Et and Fr-Me caused inhibition 
of CCh (1毺M)-induced contractions at low concentration 
with IC50 value of 6.493 mg/mL (2.517 - 16.749, 95% Cl, n=4) 
and 11.507 mg/ml (3.331-39.755, 95% Cl, n=3) respectively 
(Figure 1A). Compared to that against K+ (80 mM)-induced 
contractions with IC50 values of Fr-Et and Fr-Me were 
found to be 0.128 mg/mL (0.094 - 0.174, 95% Cl, n=3) and 
0.687 mg/mL (0.210 - 2.246,  95% Cl, n=3) respectively, 
(Figure 1A and 1B).  Verapramil was more potent against K+ 
induced contractions with IC50 value of 0.018 毺M (0.0089-
0.367, 95% Cl, n=3), when compared with CCh-induced 
contractions with IC50 value 0.272 毺M (0.175-0.421, 95%Cl, 
n=3) as shown in Figure 1C. Atropine relaxed the CCh (1 毺M)
induced contraction potentially with IC50 value of 0.003 毺M
(0.0015-0.0062, 95% CL, n=3), without any effect on K+ 
(80mM) induced contractions. (Figure 1D). 
  Fr-Et and Fr-Me also caused inhibition of histamine (1 毺M)
induced contraction (Figure 2A and 2B) respectively.  IC50 
of Fr-Et and Fr-Me against histamine induced tracheal 
contraction were found to be 0.328 mg/mL (0.141-0.765, 
95%Cl, n=3) and 0.686 mg/mL (0.529-0.889, 95% Cl, n=3) 
respectively, when compared to the standard mepyramine 
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with IC50 value of  0.0159 毺M (0.0054-0.0463, 95% Cl, n=3) 
(Figure 2C). 
3.3. Effect of Fr-Et and Fr-Me on compound 48/80 and egg 
albumin induced rat peritoneal mast cell degranulation
  Compound 48/80 (10 毺g/mL) produced disruption of 
mast cells which was significantly inhibited in a dose-
dependent manner by the treatment with Fr-Et and Fr-
Me in concentrations 0.5-2.0 mg/mL, each (Table 2). Egg 
albumin (1 mg/mL)-induced rat mast cell degranulation was 
significantly inhibited by the treatment with Fr-Et and Fr-
Me at concentrations 0.5-2.0 mg/mL, each.  The protection 
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Figure 1. Concentration-response curve showing the relaxant effect of Fr-Et (A), Fr-Me (B), verapamil (C) and  atropine (D) on K+ (80 mM) and 








































































Figure 2. Concentration-response curve showing the relaxant effect of Fr-Et (A), Fr-Me (B), mepyramine (C)  on histamine (His, 10-6M)-
induced contractions in isolated guinea-pig tracheal preparations (values shown are expressed as mean 依 SEM, n=3).
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4. Discussion
  Asthma, the atopic disease with the greatest clinical 
and economic effect[15] is an allergic and inflammatory 
outward sign of the respiratory disorders. It is essentially 
characterised by the restriction of tracheal muscles 
obstructing the air circulation, but upstream it is initiated 
by the very complicated immune process characterized by 
mucus secretion and influx of a variety of inflammatory 
cells. The partial or total reversibility of air flow obstruction 
in some patients indicates that the structural remodelling of 
the airway may occur over time. All drugs that are able to 
counteract the airflow obstruction could be also used to treat 
the pathophysiology of asthma, namely bronchodilator agents 
such as phosphodieterase inhibitors, antihistaminic[16] and 
anti-cholinergic agents, anti-inflammatory agents and 
calcium channel blockers[17]. In the present study, histamine 
and acetylcholine were used as spasmogens in the form 
of aerosol to cause immediate bronchoconstriction in the 
form of PCD in guinea pigs. Bronchodilating effect of Fr-
Me and Fr-Et were evaluated by observing its effect on the 
time of PCD. Fr-Me and Fr-Et significantly increased in a 
dose depended manner that suggestive of bronchodilating 
activity.  
  The Fr-Et and Fr-Me exhibited a significant concentration 
dependant relaxant effect on guinea pig trachea pre-
Table 1
Effect of C. cretica fractions (Fr-Me and Fr-Et) (p.o., for 7 days) on histamine and acetylcholine aerosol induced bronchospasm. 
Treatment(mg/kg)
Preconvulsion dyspnoea (PCD) time (sec)
Before Treatment After treatment % increase in the time of PCD
Histamine aerosol (0.1% w/v) Fr-Me (100) 112.80依7.35 148.40依6.15* 23.83依0.17
Fr-Me (200) 122.40依8.12  182.75依7.11** 32.79依0.15
Fr-Et (100) 127.30依6.79  217.80依9.34** 41.47依0.11
Fr-Et (200) 125.40依4.31  291.70依5.12** 56.32依0.71
Ketotifen (1) 115.60依2.34  349.50依7.19** 66.15依0.79
Acetylcholine aerosol (0.5% w/v) Fr-Me (100) 129.50依8.26 143.29依3.56*   9.12依0.54
Fr-Me (200) 131.40依6.15 168.50依5.69* 21.53依0.49
Fr-Et (100) 126.70依4.79  183.40依7.34** 30.89依0.26
Fr-Et (200) 129.80依7.29  208.90依2.95** 37.58依0.29
Atropine (2) 128.60依3.52  409.70依3.68** 68.41依0.22
 Values are expressed as mean依S.E.M. for six animals; Significantly *P<0.01; **P<0.001: statistically different (student’s paired t-test was 
applied for comparison) (n=6)
Table 2
Effect of C. cretica fractions (Fr-Me and Fr-Et) on compound 48/80 induced rat rat peritoneal mast cell degranulation. 
Treatment Concentration(mg/mL) % Mast cells degranulation依S.E.M. % Inhibition of degranulation
Negative control -   1.12依0.34 -
Positive control - 79.85依0.46 -
Fr-Me 0.50   58.12依0.72* 27.21
Fr-Me 1.00   44.19依0.63* 44.65
Fr-Me 2.00    38.15依0.29** 52.22
Fr-Et 0.50  41.25依1.24* 48.34
Fr-Et 1.00   29.82依0.43** 62.65
Fr-Et 2.00  21.05依0.13** 73.63
Ketotifen  0.01  17.25依0.34** 78.39
Values are expressed as mean依S.E.M. Comparison: All treated (both test and standard) groups with positive control group. Significantly
* P<0.01; **P<0.001.  Data were analysed by one-way analysis variance (ANOVA) followed by Dunnett’s t- test (n=6).
Table 3
Effect of C. cretica fractions (Fr-Me and Fr-Et) on egg albumin induced rat peritoneal mast cell degranulation. 
Treatment Concentration(mg/mL) % Mast cells degranulation依S.E.M. % inhibition of degranulation
Negative control -    1.31依0.82 -
Positive control -  81.23依0.45 -
Fr-Me 0.50    62.12依1.02* 23.52
Fr-Me 1.00     45.34依0.89** 44.18
Fr-Me 2.00     34.19依0.38** 57.90
Fr-Et 0.50     49.15依0.92** 39.49
Fr-Et 1.00     31.11依0.71** 61.70
Fr-Et 2.00     24.77依0.31** 69.50
Ketotifen   0.01 16.85依0.46 79.25
Values are expressed as mean依S.E.M. Comparison: All treated (both test and standard) groups with positive control group. Significantly 
* P<0.01; **P<0.001.  Data were analysed by one-way analysis of variance (ANOVA) followed by Dunnet’s t- test (n=6).
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contracted with CCh, K+ and histamine. Fr-Et was more 
potent in relaxing histamine and K+ and calcium induced 
contractions than CCh induced contractions in isolated 
guinea pig trachea preparation than Fr-Me. Its potency in 
relaxing the trachea is comparatively more than Fr-Me. 
The induced contraction shown by K+ (80mM) is by virtue of 
Ca2+ influx into the cells from the extracellular spaces. Ca2+ 
channel blockers tend to inhibit this indced contractions 
as a result of their inhibitory action at the Ca2+ channels[18]. 
Similarly verapramil, a standard Ca2+ channel blocker 
also relaxed the K+ induced contraction with specificity. 
Histamine and CCh are the most implicated mediators 
of brochoconstriction that accompanying asthma[19]. 
Smooth muscles contraction, in response to agonists like 
histamine or acetylcholine is initiated by the increase of the 
cytosolic-free Ca2+ concentration ([ca2+]i ).  These agonists, 
by activating phospholipase C produce inositol 1,4,5-
triphosphate (IP3) which in its turn stimulates sarcoplasmic 
reticulum (SR) to release the internal Ca2+ stores[20]. This 
released Ca2+ stimulates the entrance of the external Ca2+ by 
the Ca2+-induced Ca2+ release pathway[21, 22]. The present 
experimental results suggested that the inhibitory effect 
of the Fr-Et is mediated possibly through a combined 
blockade of Ca2+ and histaminic receptors.
  In addition to bronchodilating activity, a significant 
number of therapeutic approaches for bronchial asthma 
have been designed based on the antagonism of specific 
mediators released from mast cells. Mast cell degranulation 
is important in the initiation of immediate responses 
following exposure to allergens. Degranulated cells liberate 
mediators of inflammation such as histamine, leukotrienes, 
platelet activating factors and chemotactic factors for 
eosinophils, neutrophils etc. from mast cells[23]. They play 
a significant role in airway inflammatory response such as 
airway eosinophilia, late asthmatic response and airway 
hyperresponsiveness as well as in immediate hypersensitivity 
reaction like bronchial contraction. Degranulation of 
mast cells has been taken as the criteria of positive 
anaphylaxis. Ketotifen, a well-known mast cell stabilizer, 
reduces synthesis of prostaglandins E2, thromboxane A2, 
leukotriene  C4 and B4. It also inhibits release of histamine, 
serotonin and other inflammatory mediators from mast 
cells. Simultaneously it blocks H1 receptors.  Mast cell 
degranulation can be elicited by the synthetic compound 
48/80, and it has been used as a direct and convenient 
reagent to study the mechanism of anaphylaxis[24]. Numerous 
reports established that stimulation with compound 48/80 or 
IgE initiates the activation of signal transduction pathway 
which leads to histamine release. Several recent studies 
shown that compound 48/80 and other polybasic compounds 
directly activate G-proteins[25]. Compound 48/80 increases 
the permeability of the lipid bilayer membrane by causing 
the perturbation in the membrane. The intracellular 
calcium pathways are crucial to the degranulation of mast 
cells. Agents that stimulate an intracellular calcium level 
have been shown to induce mast cell degranulation[26]. 
Calcium movements in mast cells represent a major target 
for effective antiallergic drugs, as this is an essential event 
linking stimulation to secretion. Most of the studies of plant 
extracts and flavonoids as an antiallergic agents showed 
that attenuation of compound 48/80 induced intracellular 
calcium in mast cells was strongly speculated that decreased 
intracellular calcium involved in the inhibitory effect of 
histamine release and might have membrane stabilizing 
activity through inhibition of G-protein activation[27]. A 
significant protection of rat peritoneal mast cells from 
disruption by antigen and compound 48/80 by the fractions 
of C. cretica (Fr-Et and Fr-Me) points towards its ability 
to interfere the release and/or synthesis of mediators of 
inflammation, indicating its mast cell stabilizing activity in a 
dose depended manner.  
  Egg albumin is an inciting allergen which induces the 
release of mediators such as histamine and proinflammatory 
cytokines and can be elicited by various stimuli. The 
degranulation of mast cell occur in response to the 
immunological stimuli in which antigen and antibody 
reactions are predominant[28, 29]. The effect of Fr-Me 
and Fr-Et on egg albumin induced degranulation of 
mast cell showed significant protection of mast cell from 
degranulation.
  To this end the fraction (Fr-Et) led to the isolation of 
the phytoconstituents. From that we isolated1,2benzopy
rone(coumarin),7hydroxycoumarin(umbelliferone),7,8d
ihydroxycoumarin (daphnetin), 3,5,7,3’,4’pentahydroxy 
f l avono id (querce t in )  and  3 ,5 , 7 , 4 ’  t e t rahydroxy 
flavonoid(kaempferol). Quercetin-3-O-glucoside and 
Quercetin-3-O-glucorhamnopyranoside along with some 
steroidal moieties were isolated from Fr-Me (data not 
shown).  It can be suggested that coumarin may stimulate 
the enzyme endothelium NO synthase (eNOS) and provokes 
the production of NO. It is reported that endogenous 
NO stimulates soluble guanylyl cyclase, which in turn 
generates intracellular cGMP and causes airway smooth 
muscle relaxation[30]. However, a bronchodilator activity 
of coumarin and simple derivatives may also be mediated 
by another mechanism, probably the redistribution of the 
internal calcium which may decrease the cytoplasm calcium 
concentration and subsequently provokes a broncho-
dilation[31].  In the present study, we found also that Fr-Et 
had in vivo protective effect against histamine inhalation, 
and this is in line with a previous study in which protective 
anti-allergic effects of coumarin in experimental asthma 
was reported. Although coumarin itself was reported to have 
a low bioavailability in man due to extensive first-pass 
hepatic conversion to 7-hydroxycoumarin (umbelliferone) 
followed by glucuronidation[32], these metabolites might 
explain the observed lasting effect of C. cretica in the 
management of asthma. Moreover in Fr-Me on isolation 
yielded different flavonoids and steroids and that are 
reported to be antiallergenic and antihistaminic. Several 
flavonoids have been shown to possess smooth muscle 
relaxant and bronchodilator activity[33]. The flavonoids 
were known to inhibit basophil histamine release and 
neutrophil β-glucuronidase release, and there by possess 
in vivo antiallergic activity[34-36]. These flavonoids also 
inhibited the histamine release induced by compound 48/80. 
The potentiality of the plant as antitussive activity, anti-
inflammatory activity and antioxidant activity along with 
the present findings as a bronchorelaxant and mast cell 
stabilizing property suggests the therapeutic efficacy of the 
plant in treating asthma. 
  Hence the plant warrants further investigations for detailed 
study. Our research team is engaged in identifying the 
presence of other constituents and the relative concentration 
of each constituents present in the plant and their probable 
mechanism of action.
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